开发基于天然产品的向蛋白质降解剂作为抗癌剂
Cheng Chen1, Yanyan Feng1, Chen Zhou2
1School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
天然产品正在为癌症治疗带来革命性的向蛋白质降解 (TPD). 本综述探讨了基于NP的PROTAC,分子和HyTing技术,强调了它们的抗癌潜力和未来的机会.
科学领域:
- 生物化学和药理学 生物化学和药理学
- 药用化学 医学化学
- 在瘤学瘤学.
背景情况:
- 有针对性的蛋白质降解 (TPD) 提供了一种新的药理策略,以消除引起疾病的蛋白质.
- 自然产品 (NPs) 是抗癌药物的丰富来源,并为TPD技术的发展做出了重大贡献.
研究的目的:
- 审查用于抗癌应用的天然产品衍生向蛋白质降解剂 (PROTAC,MGs,HyTing) 的最新进展.
- 讨论基于NP的降解剂在扩大TPD工具箱及其未来治疗机会方面的潜力.
主要方法:
- 基于天然产品的向蛋白质降解技术的综合文献综述.
- 对NP衍生的E3酶连接体,感兴趣的蛋白质 (POI) 弹头和疏水标签 (HyTs) 的分析.
主要成果:
- 自然产品为开发PROTACs,MGs和HyTing剂提供了多样化的分子成分.
- 基于NP的降解剂显示出作为一种新型抗癌疗法的显著前景.
结论:
- 自然产品对于推进瘤学中向蛋白质降解策略至关重要.
- 对NP衍生降解剂的进一步研究为开发下一代癌症疗法提供了大量机会.
更多相关视频
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
